AAAAAA
Results:
1-15
|
Results: 15
Authors:
Hinkula, M
Pukkala, E
Kyyronen, P
Kauppila, A
Citation: M. Hinkula et al., Grand multiparity and the risk of breast cancer: population-based study inFinland, CANC CAUSE, 12(6), 2001, pp. 491-500
Authors:
Saarela, T
Risteli, J
Kauppila, A
Koivisto, M
Citation: T. Saarela et al., Effect of short-term antenatal dexamethasone administration on type I collagen synthesis and degradation in preterm infants at birth, ACT PAEDIAT, 90(8), 2001, pp. 921-925
Authors:
Simojoki, M
Santala, M
Risteli, J
Kauppila, A
Citation: M. Simojoki et al., Carboxyterminal telopeptide of type I collagen (ICTP) in predicting prognosis in epithelial ovarian cancer, GYNECOL ONC, 82(1), 2001, pp. 110-115
Authors:
Saarela, T
Risteli, J
Kauppila, A
Koivisto, M
Citation: T. Saarela et al., Type I collagen markers in cord serum of appropriate vs. small for gestational age infants born during the second half of pregnancy, EUR J CL IN, 31(5), 2001, pp. 438-443
Authors:
Simojoki, M
Santala, M
Risteli, J
Risteli, L
Kauppila, A
Citation: M. Simojoki et al., Serial determinations of aminoterminal propeptide of type III procollagen (PIIINP) and prognosis in ovarian cancer; comparison to CA125, ANTICANC R, 20(6C), 2000, pp. 4655-4660
Authors:
Launonen, V
Mannermaa, A
Stenback, F
Kosma, VM
Puistola, U
Huusko, P
Anttila, M
Bloigu, R
Saarikoski, S
Kauppila, A
Winqvist, R
Citation: V. Launonen et al., Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: correlation to clinicopathological variables, CANC GENET, 122(1), 2000, pp. 49-54
Authors:
Santala, M
Simojoki, M
Risteli, J
Risteli, L
Kauppila, A
Citation: M. Santala et al., Type I and type III collagen metabolites as predictors of clinical outcomein epithelial ovarian cancer, CLIN CANC R, 5(12), 1999, pp. 4091-4096
Authors:
Simojoki, M
Santala, M
Vuopala, S
Kauppila, A
Citation: M. Simojoki et al., The prognostic value of peritoneal cytology in ovarian cancer, EUR J GYN O, 20(5-6), 1999, pp. 357-360
Authors:
Santala, M
Jarvela, I
Kauppila, A
Citation: M. Santala et al., Transfundal insertion of a Veress needle in laparoscopy of obese subjects:a practical alternative, HUM REPR, 14(9), 1999, pp. 2277-2278
Authors:
Suvanto-Luukkonen, E
Kauppila, A
Citation: E. Suvanto-luukkonen et A. Kauppila, The levonorgestrel intrauterine system in menopausal hormone replacement therapy: five-year experience, FERT STERIL, 72(1), 1999, pp. 161-163
Authors:
Kauppila, A
Santala, M
Citation: A. Kauppila et M. Santala, New endocrine tumor markers of gynecologic malignancies - A review, ACT OBST SC, 78(10), 1999, pp. 833-837
Authors:
Johansson, J
Santala, M
Kauppila, A
Citation: J. Johansson et al., Explosive rise of serum CA 125 following the rupture of ovarian endometrioma, HUM REPR, 13(12), 1998, pp. 3503-3504
Authors:
Santala, M
Burger, H
Ruokonen, A
Stenback, F
Kauppila, A
Citation: M. Santala et al., Elevated serum inhibin and tumor-associated trypsin inhibitor concentrations in a young woman with dysgerminoma of the ovary, GYNECOL ONC, 71(3), 1998, pp. 465-468
Authors:
Launonen, V
Stenback, F
Puistola, U
Bloigu, R
Huusko, P
Kytola, S
Kauppila, A
Winqvist, R
Citation: V. Launonen et al., Chromosome 11q22.3-q25 LOH in ovarian cancer: Association with a more aggressive disease course and involved subregions, GYNECOL ONC, 71(2), 1998, pp. 299-304
Authors:
Santala, M
Risteli, J
Risteli, L
Puistola, U
Kacinski, BM
Stanley, ER
Kauppila, A
Citation: M. Santala et al., Synthesis and breakdown of fibrillar collagens: concomitant phenomena in ovarian cancer, BR J CANC, 77(11), 1998, pp. 1825-1831
Risultati:
1-15
|